During the past decade, Statens Serum Institut conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Statens Serum Institut" #1 collaborator was "Epidemic Health, Inc." with 1 trials as a collaborator, "Harvard School of Public Health (HSPH)" with 1 trials as a collaborator, "Herlev Hospital" with 1 trials as a collaborator and "Hvidovre University Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Statens Serum Institut" are "Crohns Disease" (1 trials), "Dientamoebiasis" (1 trials) and "Food Habits" (1 trials). Many other conditions were trialed in "Statens Serum Institut" in a lesser frequency.

Most popular intervention types in "Statens Serum Institut" are "Behavioral" (1 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "1: Tailored SMS program implicating friend and mother" (1 trials), "2: Standardized SMS program implicating friend and mother" (1 trials), "3: Tailored SMS program implicating friend, not mother" (1 trials), "4: Standardized SMS program implicating friend, not mother" (1 trials) and "5: Tailored SMS program implicating mother, not friend" (1 trials). Other intervention names were less common.

The vast majority of trials in "Statens Serum Institut" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Statens Serum Institut". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Statens Serum Institut, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Statens Serum Institut, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".